Iroko Pharmaceuticals Makes Strategic Additions To The Company’s Board Of Directors
2/18/2014 6:45:12 AM
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced the appointment of Bradley T. Sheares, Ph.D. and Louis Vollmer to the board of directors of Iroko Pharmaceuticals Inc. Dr. Sheares and Mr. Vollmer bring more than 50 years of combined pharmaceutical marketing experience, having held senior leadership positions at Reliant Pharmaceuticals, Inc., Merck & Co., DuPont Pharmaceuticals, and Endo Pharmaceuticals Inc.
Help employers find you! Check out all the jobs and post your resume.
comments powered by